Suchergebnisse - (Subject:"2494G1JF75")

PubPharm (2.236)

101

Letter to the Editor : Pharmacokinetics of Lopinavir/Ritonavir in Hospitalized Patients with COVID-19 Not Requiring Critical Care

enthalten in: Microbial drug resistance (Larchmont, N.Y.) | 2022

von MacGowan, A. | Hamilton, F. | Bayliss, M. | +8

CommentOn: Ann Intern Med. 2020 Oct 20;173(8):670-672. - PMID 32422065

102

Slower Recovery with Early Lopinavir/Ritonavir use in Pediatric COVID-19 Patients : A Retrospective Observational Study

enthalten in: Paediatric drugs | 2022

von Wong, C. | Low, M. | Kwok, A. | +8

103

Quality of life and associated factors among people receiving second-line anti-retroviral therapy in Johannesburg, South Africa

enthalten in: BMC infectious diseases | 2022

von Mokgethi, N. | Christofides, N. | Machisa, M. | +2

104

Agreement of treatment effects from observational studies and randomized controlled trials evaluating hydroxychloroquine, lopinavir-ritonavir, or dexamethasone for covid-19 : meta-epidemiological study

enthalten in: BMJ (Clinical research ed.) | 2022

von Moneer, O. | Daly, G. | Skydel, J. | +4

105

Combination of QSAR, molecular docking, molecular dynamic simulation and MM-PBSA : analogues of lopinavir and favipiravir as potential drug candidates against COVID-19

enthalten in: Journal of biomolecular structure & dynamics | 2022

von Rafi, M. | Bhattacharje, G. | Al-Khafaji, K. | +5

106

Hospital compounding to face shortage : A case study of the development of a lopinavir-ritonavir oral suspension during the first wave of SARS-COV-2 in France

enthalten in: Annales pharmaceutiques francaises | 2022

von Secretan, P. | Thirion, O. | Vieillard, V. | +4

107

Effects of Drugs Formerly Proposed for COVID-19 Treatment on Connexin43 Hemichannels

enthalten in: International journal of molecular sciences | 2022

von Cooreman, A. | Caufriez, A. | Tabernilla, A. | +7

108

Meta-analysis of arbidol versus lopinavir/ritonavir in the treatment of coronavirus disease 2019

enthalten in: Journal of medical virology | 2022

von Yu, M. | Wang, D. | Li, S. | +3

109

Predictive factors of six-week mortality in critically ill patients with SARS-CoV-2 : A multicenter prospective study

enthalten in: Medicina intensiva | 2022

von Estella, �. | Garcia Garmendia, J. | de la Fuente, C. | +39

110

Ritonavir and COVID-19 : pragmatic guidance is important

enthalten in: Lancet (London, England) | 2022

von Waters, L. | Marra, F. | Pozniak, A. | +2

CommentOn: Lancet. 2022 Jan 1;399(10319):21-22. - PMID 34973713